Response of cats with dilated cardiomyopathy to taurine supplementation.

P. D. Pion, Mark D Kittleson, W. P. Thomas, L. A. Delellis, Quinton Rogers

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Between October 1986 and September 1988, 37 cats with moderate to severe idiopathic myocardial failure (dilated cardiomyopathy) were evaluated. Clinical management of these cats was similar to that described in the literature, except that it also included administration of 500 or 1,000 mg of the sulfur amino acid, taurine per day. Early death (death within the first 30 days of treatment) occurred in 14 (38%) cats. One cat was lost to follow-up evaluation. Twenty-two cats (59%) had marked clinical and echocardiographic improvement and survived longer than 240 days. In all but 1 cat, the observed improvement in echocardiographic measurements persisted. Hypothermia and thromboembolism were positively associated with an increased risk of early death. Administration of digoxin did not significantly affect survival. All 22 cats that survived greater than 30 days remained clinically stable despite withdrawal of all medications except taurine. Administration of taurine was eventually discontinued in 20 of the 22 cats and adequate taurine intake was thereafter provided for in the food. The clinical response and 1-year survival rate of 58% (21 of 36 cats with a known outcome) in the taurine-treated group represents a marked improvement, compared with a 1-year survival rate of 13% (4 of 31 cats with a known outcome) in a retrospectively evaluated population of 33 cats with dilated cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)275-284
Number of pages10
JournalJournal of the American Veterinary Medical Association
Volume201
Issue number2
StatePublished - Jul 15 1992

Fingerprint

Taurine
cardiomyopathy
taurine
Dilated Cardiomyopathy
Cats
cats
death
survival rate
digoxin
Sulfur Amino Acids
sulfur amino acids
hypothermia
Lost to Follow-Up
Thromboembolism
Digoxin
heart failure
Hypothermia
drug therapy
Heart Failure
Food

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Response of cats with dilated cardiomyopathy to taurine supplementation. / Pion, P. D.; Kittleson, Mark D; Thomas, W. P.; Delellis, L. A.; Rogers, Quinton.

In: Journal of the American Veterinary Medical Association, Vol. 201, No. 2, 15.07.1992, p. 275-284.

Research output: Contribution to journalArticle

@article{e3ef94ff41d34d5192ddc786de1e5562,
title = "Response of cats with dilated cardiomyopathy to taurine supplementation.",
abstract = "Between October 1986 and September 1988, 37 cats with moderate to severe idiopathic myocardial failure (dilated cardiomyopathy) were evaluated. Clinical management of these cats was similar to that described in the literature, except that it also included administration of 500 or 1,000 mg of the sulfur amino acid, taurine per day. Early death (death within the first 30 days of treatment) occurred in 14 (38{\%}) cats. One cat was lost to follow-up evaluation. Twenty-two cats (59{\%}) had marked clinical and echocardiographic improvement and survived longer than 240 days. In all but 1 cat, the observed improvement in echocardiographic measurements persisted. Hypothermia and thromboembolism were positively associated with an increased risk of early death. Administration of digoxin did not significantly affect survival. All 22 cats that survived greater than 30 days remained clinically stable despite withdrawal of all medications except taurine. Administration of taurine was eventually discontinued in 20 of the 22 cats and adequate taurine intake was thereafter provided for in the food. The clinical response and 1-year survival rate of 58{\%} (21 of 36 cats with a known outcome) in the taurine-treated group represents a marked improvement, compared with a 1-year survival rate of 13{\%} (4 of 31 cats with a known outcome) in a retrospectively evaluated population of 33 cats with dilated cardiomyopathy.",
author = "Pion, {P. D.} and Kittleson, {Mark D} and Thomas, {W. P.} and Delellis, {L. A.} and Quinton Rogers",
year = "1992",
month = "7",
day = "15",
language = "English (US)",
volume = "201",
pages = "275--284",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "2",

}

TY - JOUR

T1 - Response of cats with dilated cardiomyopathy to taurine supplementation.

AU - Pion, P. D.

AU - Kittleson, Mark D

AU - Thomas, W. P.

AU - Delellis, L. A.

AU - Rogers, Quinton

PY - 1992/7/15

Y1 - 1992/7/15

N2 - Between October 1986 and September 1988, 37 cats with moderate to severe idiopathic myocardial failure (dilated cardiomyopathy) were evaluated. Clinical management of these cats was similar to that described in the literature, except that it also included administration of 500 or 1,000 mg of the sulfur amino acid, taurine per day. Early death (death within the first 30 days of treatment) occurred in 14 (38%) cats. One cat was lost to follow-up evaluation. Twenty-two cats (59%) had marked clinical and echocardiographic improvement and survived longer than 240 days. In all but 1 cat, the observed improvement in echocardiographic measurements persisted. Hypothermia and thromboembolism were positively associated with an increased risk of early death. Administration of digoxin did not significantly affect survival. All 22 cats that survived greater than 30 days remained clinically stable despite withdrawal of all medications except taurine. Administration of taurine was eventually discontinued in 20 of the 22 cats and adequate taurine intake was thereafter provided for in the food. The clinical response and 1-year survival rate of 58% (21 of 36 cats with a known outcome) in the taurine-treated group represents a marked improvement, compared with a 1-year survival rate of 13% (4 of 31 cats with a known outcome) in a retrospectively evaluated population of 33 cats with dilated cardiomyopathy.

AB - Between October 1986 and September 1988, 37 cats with moderate to severe idiopathic myocardial failure (dilated cardiomyopathy) were evaluated. Clinical management of these cats was similar to that described in the literature, except that it also included administration of 500 or 1,000 mg of the sulfur amino acid, taurine per day. Early death (death within the first 30 days of treatment) occurred in 14 (38%) cats. One cat was lost to follow-up evaluation. Twenty-two cats (59%) had marked clinical and echocardiographic improvement and survived longer than 240 days. In all but 1 cat, the observed improvement in echocardiographic measurements persisted. Hypothermia and thromboembolism were positively associated with an increased risk of early death. Administration of digoxin did not significantly affect survival. All 22 cats that survived greater than 30 days remained clinically stable despite withdrawal of all medications except taurine. Administration of taurine was eventually discontinued in 20 of the 22 cats and adequate taurine intake was thereafter provided for in the food. The clinical response and 1-year survival rate of 58% (21 of 36 cats with a known outcome) in the taurine-treated group represents a marked improvement, compared with a 1-year survival rate of 13% (4 of 31 cats with a known outcome) in a retrospectively evaluated population of 33 cats with dilated cardiomyopathy.

UR - http://www.scopus.com/inward/record.url?scp=0027120606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027120606&partnerID=8YFLogxK

M3 - Article

C2 - 1500324

AN - SCOPUS:0027120606

VL - 201

SP - 275

EP - 284

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 2

ER -